Retacrit (epoetin alfa-epbx) is used to treat anemia. Retacrit is a biosimilar to epogen (epoetin-alfa). iosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Retacrit may be covered by your Medicare or insurance plan.
Retacrit is a brand name of epoetin alfa, a medicine used to treat anemia. Learn about the serious side effects of Retacrit, such as increased risk of death, stroke, and tumor progression, and the less common but still important side effects, such as nausea, headache, and rash.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RETACRIT safely and effectively. See full prescribing information for RETACRIT. RETACRIT (epoetin alfa-epbx) injection, for i ntravenous or subcutaneous use . Initial U.S. Approval: 2024
Retacrit - Eprex) Pronunciation Epoetin Nursing Considerations, Side Effects, and Mechanism of Action Pharmacology for Nurses.
and other clinical safety and effectiveness data that demonstrates Retacrit is biosimilar to Epogen/Procrit. Retacrit has been approved as a
Retacrit can also lead to skin rash and influenza (flu)-like symptoms. For the full list of all side effects reported with Retacrit, see the package leaflet.
Side Effects. Retacrit Side Effects: Allergic Reactions Breathing Problems Chest Pain Chills Confusion Cough Dizziness Fever Headache Itching
What is Retacrit? Retacrit is a solution for injection. It is available in prefilled syringes containing between 1,0,000 international units (IU) of
†RETACRIT does not have a designation of interchangeability with Epogen/Procrit.2. ‡As of September 2024. RETACRIT (epoetin alfa-epbx) product and.
Comments
one of my own pet peeves, sorry
The story was awesome...
Given all the side effects of mostly untested medications I could honestly see this happening to someone since most new meds get pulled within 5 years because of the side effects.